Company Number: SC759981

Analysis Date: 2025-07-29 14:56 UTC

Financial Health Assessment: ARKAIG HYDROGEN PLANT LIMITED
(Financial Year Ending 31 March 2024)

---

1. Financial Health Score: D

Explanation:
The company’s financial “vital signs” indicate significant distress with net liabilities and a negative working capital position. Though the company is newly incorporated and early in its lifecycle, the current position signals urgent attention is needed to avoid further deterioration.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Fixed Assets	520	Minimal long-term investments; typical for a startup or early-stage company.
Current Assets	71,867	Cash or short-term assets available; positive but insufficient relative to liabilities.
Current Liabilities	155,708	Obligations due within one year; exceeds current assets significantly.
Net Current Assets (Working Capital)	-83,841	Negative working capital; a key "symptom" of liquidity stress.
Total Assets Less Current Liabilities	-83,320	Net liabilities after deducting current liabilities; indicates financial strain.
Net Assets (Shareholders’ Funds)	-83,320	Negative equity; shareholders’ funds are in deficit, reflecting accumulated losses or funding gaps.

Additional Context:

• No employees during the period (0 employees), consistent with an early-stage or development phase company.
• Company is a micro-entity, limiting detailed financial disclosures but still indicating core financial health.
• 75-100% ownership and control by Haldane Energy Limited, suggesting potential parent company backing or internal funding.
• Industry: Production of electricity (SIC 35110), capital intensive and possibly long gestation period before revenue generation.

---

3. Diagnosis

Symptoms of Financial Distress:

• The company shows negative net assets of £83,320, meaning liabilities exceed assets. This is akin to the body showing signs of “nutrient deficiency” or “energy depletion.”
• Negative working capital (-£83,841) signals liquidity difficulties—current obligations cannot be met with available short-term assets. This is a classic symptom of “cash flow distress.”
• The company has no employees and minimal fixed assets, indicating it is likely in the pre-operational or development phase, possibly investing heavily without revenue yet. This “early disease stage” is common in startups but requires careful management of cash flow.
• The absence of audit and simplified micro-entity reporting means less detail is available, but the fundamental indicators point to a fragile financial state.

Underlying Causes:

• The company may be in the capital build-up phase, incurring expenses ahead of revenue inflows typical for an infrastructure or energy project.
• Reliance on the parent company (Haldane Energy Limited) for capital injections or guarantees may explain ongoing operations despite negative equity.
• Without active revenue or operational scale, the company’s current financial health depends heavily on external funding and effective cash flow management.

---

4. Recommendations

Immediate Actions (Stabilizing the Patient):

• Assess and secure funding sources: Confirm the availability and timing of additional capital injections from Haldane Energy Limited or other investors to cover short-term liabilities and operational costs.
• Implement strict cash flow management: Monitor and plan outflows meticulously to avoid liquidity crises. Introduce financial controls to prioritize essential payments.
• Develop a clear operational timeline: Establish milestones for transitioning from development to operational phase to improve revenue visibility.

Medium to Long-term Actions (Building Financial Resilience):

• Enhance asset base: Invest strategically in fixed assets required for electricity production to build company value and operational capability.
• Plan for revenue generation: Outline commercial contracts, power purchase agreements, or partnerships that will generate steady income.
• Regular financial health monitoring: Adopt more detailed financial reporting beyond micro-entity exemptions as the company grows, to detect “symptoms” early and adjust treatment.
• Explore cost optimization: Evaluate overheads and project expenses to reduce burn rate before revenue stabilizes.

---